Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03242382
Title Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (PalboSarc)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Espanol de Investigacion en Sarcomas
Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST